Historical record - last NADAC effective date: 2/22/2017
Product Information
OSENI 25-15 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $12.0092 per EA under NDC 64764025103. Its NADAC has been published 225 times since Nov 28, 2013.
FDA first approved this application on Jan 25, 2013.
Strength
25; 15 mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764025103
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022426FDA Approved
1/25/2013
On Market Since
1/25/2013
Pharmacological Classes
Price Statistics
The NADAC for OSENI 25-15 MG TABLET has been published 225 times since Nov 28, 2013, and over the history we have for it it has risen 49.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.0092 per EA |
|---|---|
| All-time high | $12.1135 (Feb 15, 2017) |
| All-time low | $8.0200 (Nov 28, 2013) |
| Median price | $11.0211 |
| Average price | $10.7764 |
| Largest weekly change | +15.4% (Jan 15, 2014) |
| Weeks tracked | 225 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+49.7%
Last surveyed Mar 14, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the alogliptin and pioglitazone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Takeda Pharmaceuticals America, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
alogliptin and pioglitazone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dipeptidyl Peptidase 4 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSENI 25-15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OSENI 25-15 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $12.0092 per EA (NDC 64764025103), effective Mar 14, 2018.
How has the price of OSENI 25-15 MG TABLET changed over time?
Over the history we have for it, the NADAC for OSENI 25-15 MG TABLET has risen 49.7%. It has been tracked across 225 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OSENI 25-15 MG TABLET?
Since Nov 28, 2013, the NADAC for OSENI 25-15 MG TABLET has ranged from a low of $8.0200 (Nov 28, 2013) to a high of $12.1135 (Feb 15, 2017), with a median of $11.0211 per EA.
Are there cheaper alternatives to OSENI 25-15 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of OSENI 25-15 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OSENI 25-15 MG TABLET?
OSENI 25-15 MG TABLET (NDC 64764025103) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.